Ligutan, Jasmin P.
HRN: 23-56-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/22/2023
CEFUROXIME 1.5GM (VIAL)
09/23/2023
09/23/2023
IV
1.5gms
Prior To OR
Repeat CS With BTL
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes